#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Dermatomyositis Nasopharyngeal cancer Aspergillus infection Metastases to central nervous system Friedreich's ataxia Colorectal cancer metastatic Chronic graft versus host disease in intestine Propionic acidaemia Familial hypertriglyceridaemia Amyotrophic lateral sclerosis gene carrier Acute promyelocytic leukaemia Chondrosarcoma Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency Small intestine leiomyosarcoma Post transplant lymphoproliferative disorder More trials…

    Learn about Rare Diseases

    Osteosarcoma – Life with Disease Langerhans’ cell histiocytosis – Treatment Leiomyosarcoma – Treatment Turner’s syndrome – Treatment Focal segmental glomerulosclerosis – Diagnostics Hereditary neuropathic amyloidosis – Treatment Niemann-Pick disease – Trials in Disease Encephalitis autoimmune – Basic Information Ehlers-Danlos syndrome Cytokine release syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ampreloxetine Mr0005 Ima402 Soft Paraffin And Fat Products LUNRESERTIB Sapropterin Dihydrochloride IPN01195 Testosterone Undecanoate Melatonin Ivonescimab Lanifibranor Camizestrant Alectinib Hydrochloride Nintedanib M1P Dipotassium Salt Acetic Acid, Glacial Eteplirsen Pimavanserin Tartrate Selexipag Metreleptin More therapies…

    Learn about Your Condition

    Endometrial cancer stage IV Sciatica Acarodermatitis Abdominal wall pain Cold urticaria Bacteraemia Cholestatic pruritus Hyperparathyroidism secondary Hypocalcaemia Muscular dystrophy Oxygen therapy Gingival bleeding Cataract Lichen sclerosus Plasmablastic lymphoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Safety, tolerability and exploratory efficacy of PST-611 in patients with geographic atrophy secondary to age-related macular degeneration

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Dry age-related macular degeneration
    • Age-related macular degeneration
    France

  • Effect of serenoa repens on chronic prostate inflammation in men with benign prostatic hyperplasia: a phase III randomized study

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Benign prostatic hyperplasia
    Italy

  • Efficacy and Safety of SIL204 Combined with Standard Chemotherapy in Patients with Locally Advanced Pancreatic Cancer

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    • Adenocarcinoma pancreas
    Germany

  • High‑Flow Oxygen to Reduce Hypoxemia in High‑Risk Adults Undergoing Sedated Gastroscopy, Colonoscopy or Endoscopic Ultrasound

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Oxygen
    Spain

  • Low‑dose human serum albumin versus standard dose during large‑volume paracentesis in patients with liver cirrhosis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Hepatic cirrhosis
    Investigated Drugs:
    • Human Serum Albumin
    The Netherlands

  • Evaluation of Propranolol‑Enhanced Traumatic Memory Reactivation for Post‑Traumatic Stress Disorder in Women Victims of Violence

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Post-traumatic stress disorder
    Investigated Drugs:
    • Propranolol Hydrochloride
    France
Previous Page
1 … 689 690 691 692 693 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!